HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Mazurchuk Selected Research

Gemcitabine

5/2003High-resolution magnetic resonance imaging of the efficacy of the cytosine analogue 1-[2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl]-N(4)-palmitoyl cytosine (CS-682) in a liver-metastasis athymic nude mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Mazurchuk Research Topics

Disease

15Neoplasms (Cancer)
01/2020 - 05/2002
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2006 - 12/2004
2Squamous Cell Carcinoma of Head and Neck
07/2006 - 12/2004
2Carcinoma (Carcinomatosis)
07/2006 - 01/2005
2Brain Neoplasms (Brain Tumor)
03/2004 - 05/2002
1Carcinogenesis
01/2018
1Necrosis
05/2008
1Pyruvate Dehydrogenase Complex Deficiency Disease
04/2007
1Colonic Neoplasms (Colon Cancer)
02/2007
1Hemorrhage
02/2007
1Head and Neck Neoplasms (Head and Neck Cancer)
07/2006
1Fibrosarcoma
01/2005
1Phototoxic Dermatitis (Phototoxicity)
01/2005
1Hypoxia (Hypoxemia)
12/2004
1Neoplasm Metastasis (Metastasis)
05/2003
1Gliosarcoma
05/2002

Drug/Important Bio-Agent (IBA)

51-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2010 - 01/2005
42-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a (HPPH)IBA
05/2010 - 01/2005
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2012 - 05/2002
3pyropheophorbide aIBA
05/2010 - 01/2005
3Photosensitizing Agents (Photosensitizers)IBA
05/2010 - 06/2005
3Pharmaceutical PreparationsIBA
05/2008 - 03/2004
3vadimezanIBA
02/2007 - 06/2005
2Biological ProductsIBA
01/2018 - 01/2018
2Pentetic Acid (DTPA)FDA LinkGeneric
05/2010 - 01/2005
2AcidsIBA
05/2010 - 06/2005
2Contrast MediaIBA
02/2007 - 06/2005
2Fluorouracil (Carac)FDA LinkGeneric
12/2004 - 05/2003
2Liposomes (Liposome)IBA
03/2004 - 05/2002
1Proteins (Proteins, Gene)FDA Link
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1CarcinogensIBA
01/2018
1liposomal doxorubicin (Doxil)FDA Link
12/2012
1Angiogenesis InhibitorsIBA
12/2012
1cadherin 5IBA
12/2012
1diethylenetriamineIBA
05/2010
1GadoliniumIBA
05/2010
1Chlorophyll AIBA
05/2010
1Oxygen (Dioxygen)IBA
05/2008
1Evans Blue (Blue, Evans)FDA Link
05/2008
1Protons (Proton)IBA
04/2007
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
02/2007
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2007
1AT 112IBA
06/2005
1methyl cellosolve (ethylene glycol monomethyl ether)IBA
01/2005
1Ether (Diethyl Ether)IBA
01/2005
1Carbonic Anhydrase IXIBA
12/2004
1Irinotecan (Camptosar)FDA LinkGeneric
12/2004
1pimonidazoleIBA
12/2004
1involucrinIBA
12/2004
1Differentiation AntigensIBA
12/2004
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2004
1Paclitaxel (Taxol)FDA LinkGeneric
03/2004
1Drug CarriersIBA
03/2004
1CytosineIBA
05/2003
1sapacitabineIBA
05/2003
1GemcitabineFDA Link
05/2003

Therapy/Procedure

6Therapeutics
01/2020 - 03/2004
3Photochemotherapy (Photodynamic Therapy)
05/2010 - 06/2005
3Aftercare (After-Treatment)
02/2007 - 06/2005
2Drug Therapy (Chemotherapy)
01/2005 - 12/2004
1Immunotherapy
01/2020
1Phototherapy (Light Therapy)
05/2010
1Lasers (Laser)
05/2008
1Combination Drug Therapy (Combination Chemotherapy)
12/2004